Trial Outcomes & Findings for Patient Self-sampling of HPV to Screen for Cervical Cancer (NCT NCT05600283)
NCT ID: NCT05600283
Last Updated: 2026-01-06
Results Overview
Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection
COMPLETED
NA
222 participants
Baseline (sample was collected up to 21 days form the date of registration)
2026-01-06
Participant Flow
Group 1: eligible participants enrolled = 89 (98 participants initially deemed eligible; 9 participants declined to participate) Group 2: eligible participants enrolled = 133 (207 participants initially deemed eligible; 74 declined to participate)
Participant milestones
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
|---|---|---|
|
Overall Study
STARTED
|
89
|
133
|
|
Overall Study
COMPLETED
|
79
|
115
|
|
Overall Study
NOT COMPLETED
|
10
|
18
|
Reasons for withdrawal
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
3
|
8
|
|
Overall Study
Invalid Vaginal Swab
|
2
|
2
|
|
Overall Study
Missing Clinician Collection
|
3
|
6
|
|
Overall Study
Screen Failure
|
1
|
2
|
|
Overall Study
Sample Lost in Transit
|
1
|
0
|
Baseline Characteristics
Patient Self-sampling of HPV to Screen for Cervical Cancer
Baseline characteristics by cohort
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
n=127 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Total
n=208 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
81 Participants
n=37 Participants
|
127 Participants
n=56 Participants
|
208 Participants
n=82 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Sex: Female, Male
Female
|
81 Participants
n=37 Participants
|
127 Participants
n=56 Participants
|
208 Participants
n=82 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
4 Participants
n=37 Participants
|
5 Participants
n=56 Participants
|
9 Participants
n=82 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
77 Participants
n=37 Participants
|
122 Participants
n=56 Participants
|
199 Participants
n=82 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=37 Participants
|
2 Participants
n=56 Participants
|
2 Participants
n=82 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=37 Participants
|
1 Participants
n=56 Participants
|
1 Participants
n=82 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=37 Participants
|
3 Participants
n=56 Participants
|
3 Participants
n=82 Participants
|
|
Race (NIH/OMB)
White
|
72 Participants
n=37 Participants
|
114 Participants
n=56 Participants
|
186 Participants
n=82 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=37 Participants
|
0 Participants
n=56 Participants
|
0 Participants
n=82 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
9 Participants
n=37 Participants
|
7 Participants
n=56 Participants
|
16 Participants
n=82 Participants
|
|
Region of Enrollment
United States
|
81 participants
n=37 Participants
|
127 participants
n=56 Participants
|
0 participants
n=82 Participants
|
PRIMARY outcome
Timeframe: Baseline (sample was collected up to 21 days form the date of registration)Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection
Outcome measures
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=79 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
n=115 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
|---|---|---|
|
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
HPV18
|
99 Total Percentage Agreement
|
95 Total Percentage Agreement
|
|
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
Other HPV
|
86 Total Percentage Agreement
|
89 Total Percentage Agreement
|
|
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
HPV16
|
98 Total Percentage Agreement
|
94 Total Percentage Agreement
|
SECONDARY outcome
Timeframe: Baseline (sample was collected up to 21 days form the date of registration)Population: Survey results are reported for all participants who completed vaginal self-collection and returned the survey, even if the self-collection sample was deemed invalid or clinician sample was not received.
Assessed by survey question "Overall, how acceptable was it for you to collect the sample using the Evalyn® brush?," which was answered on a 4-point scale (completely unacceptable, unacceptable, acceptable, or completely acceptable).
Outcome measures
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
n=126 Participants
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
|---|---|---|
|
Patient-reported Acceptability of Using the Evalyn Brush
Completely unacceptable
|
0 Participants
|
0 Participants
|
|
Patient-reported Acceptability of Using the Evalyn Brush
Unacceptable
|
0 Participants
|
1 Participants
|
|
Patient-reported Acceptability of Using the Evalyn Brush
Acceptable
|
15 Participants
|
37 Participants
|
|
Patient-reported Acceptability of Using the Evalyn Brush
Completely acceptable
|
66 Participants
|
88 Participants
|
Adverse Events
Group 1: Self-collected Vaginal Swab Samples at Clinic
Group 2: Self-collected Vaginal Swab Samples at Home
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Group 1: Self-collected Vaginal Swab Samples at Clinic
n=81 participants at risk
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
Group 2: Self-collected Vaginal Swab Samples at Home
n=127 participants at risk
Subjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Swab kit (COBAS HPV 4800 Assay -Evalyn brush): Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Clinician-collection of cervical sample for HPV testing: Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
|
|---|---|---|
|
Product Issues
Participant inserted self-collection device with cap on (did not remove cap)
|
2.5%
2/81 • Number of events 2 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
|
0.00%
0/127 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
|
|
Product Issues
Device damaged during mailing to patient
|
0.00%
0/81 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
|
0.79%
1/127 • Number of events 1 • Baseline (at the time of swab collection). Participants collected swab samples up to 21 days from the time of enrollment.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place